Bosnia and Herzegovina - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes
Since 2014, Bosnia and Herzegovina Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes increased 3.5% year on year. In 2019, the country was number 33 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes with €42.73 Per Capita. Switzerland ranked the highest with €666.37 Per Capita in 2019, that is a growth of 3.2% versus 2018. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia recorded the best 5 years average growth at +8.8% per year, while Romania recorded the worst performance at -1.7% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 42.73 |
2018 | 42.11 |
2017 | 42.39 |
2016 | 42.80 |
2015 | 39.55 |
How does Bosnia and Herzegovina rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?
# | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Switzerland
|
666.37 | 2019 | +3.1 % | +5.3 % | View data | |
2 |
#2
Germany
|
553.39 | 2019 | +2.3 % | +3.0 % | View data | |
32 |
#32
Cyprus
|
50.16 | 2019 | -3.4 % | +1.4 % | View data | |
33 |
#33
Bosnia and Herzegovina
|
42.73 | 2019 | +1.5 % | +3.5 % | View data |